Literature DB >> 2976764

Atrial natriuretic factor in various stages of diabetic nephropathy.

P T Sawicki1, L Heinemann, K Rave, A Hohmann, M Berger.   

Abstract

Plasma concentrations of atrial natriuretic factor (ANF) were measured by radioreceptor assay in 148 insulin-dependent Type I diabetic patients with different stages of diabetic nephropathy. In patients with overt or incipient diabetic nephropathy as well as in patients with glomerular hyperfiltration only, ANF concentrations were elevated when compared with non-nephropathic diabetic and normal subjects. No correlations between ANF and blood pressure, age, diabetes duration, or parameters of metabolic control were found. These findings may indicate a pathophysiologic role of ANF in the development and progression of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976764     DOI: 10.1016/s0891-6632(88)80010-2

Source DB:  PubMed          Journal:  J Diabet Complications        ISSN: 0891-6632


  4 in total

1.  Elevated plasma concentrations of atrial and brain natriuretic peptide in type 1 diabetic subjects.

Authors:  K McKenna; D Smith; M Sherlock; K Moore; E O'Brien; W Tormey; C J Thompson
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

2.  Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

Authors:  E Jungmann; A Felber; S Graeber; U Hillmann; T Haak; K D Palitzsch; K H Usadel
Journal:  Clin Investig       Date:  1993-08

3.  Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus.

Authors:  L A Sechi; J P Valentin; C A Griffin; E Lee; E Bartoli; M H Humphreys; M Schambelan
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.

Authors:  K Sakamoto; R Kikkawa; M Haneda; Y Shigeta
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.